Abstract Today, scientists are often encouraged to custom-design vaccines based on a particular country or clade. Here, we review the scientific literature and then suggest that the overwhelming endeavor to produce a unique vaccine for every world region or virus subtype may not be necessary.</p
HIV/AIDS remains one of the most important current threats to global public health. Since its identi...
The development of biomedical interventions to reduce acquisition of HIV-1 infection remains a globa...
A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences i...
Today, scientists are often encouraged to custom-design vaccines based on a particular country or cl...
Today, scientists are often encouraged to custom-design vaccines based on a particular country or cl...
As HIV-1 envelope immune responses are critical to vaccine related protection, most candidate HIV va...
AbstractAs HIV-1 envelope immune responses are critical to vaccine related protection, most candidat...
Global HIV-1 genetic diversity forms a major obstacle to the development of an HIV vaccine. It may b...
Global HIV-1 genetic diversity forms a major obstacle to the development of an HIV vaccine. It may b...
Development of an HIV vaccine presents a formidable challenge. One of the unresolved, yet central is...
A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences i...
Despite the great success of antiretroviral therapy, both in the treatment and prevention of HIV-1 i...
A major obstacle to the design of a global HIV-1 vaccine is viral diversity. At present, data sugges...
BACKGROUND: One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversit...
The high level of genetic diversity of HIV-1 poses a major challenge for global vaccine development....
HIV/AIDS remains one of the most important current threats to global public health. Since its identi...
The development of biomedical interventions to reduce acquisition of HIV-1 infection remains a globa...
A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences i...
Today, scientists are often encouraged to custom-design vaccines based on a particular country or cl...
Today, scientists are often encouraged to custom-design vaccines based on a particular country or cl...
As HIV-1 envelope immune responses are critical to vaccine related protection, most candidate HIV va...
AbstractAs HIV-1 envelope immune responses are critical to vaccine related protection, most candidat...
Global HIV-1 genetic diversity forms a major obstacle to the development of an HIV vaccine. It may b...
Global HIV-1 genetic diversity forms a major obstacle to the development of an HIV vaccine. It may b...
Development of an HIV vaccine presents a formidable challenge. One of the unresolved, yet central is...
A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences i...
Despite the great success of antiretroviral therapy, both in the treatment and prevention of HIV-1 i...
A major obstacle to the design of a global HIV-1 vaccine is viral diversity. At present, data sugges...
BACKGROUND: One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversit...
The high level of genetic diversity of HIV-1 poses a major challenge for global vaccine development....
HIV/AIDS remains one of the most important current threats to global public health. Since its identi...
The development of biomedical interventions to reduce acquisition of HIV-1 infection remains a globa...
A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences i...